Diagnostic screening programs help catch cancer, abnormalities or other diseases before they reach an advanced stage, saving lives and healthcare costs. Screening programs include, lung, breast, prostate, and cervical cancer, among many others.
New findings support the routine use of deep learning-based risk assessments, as this method can decrease subjectivity, reduce unnecessary imaging and improve diagnostic accuracy.
The COlorectal Cancer detection with AI, or COCA, model is a cost-effective, scalable solution that turns routine CT scans into opportunistic exams that can be used to proactively identify CRC.
Two respected radiology organizations have issued a stark warning on the new recommendations, stating that they risk confusing patients and “may contribute to thousands of additional breast cancer deaths each year.”
Individuals at high risk of pancreatic cancer benefit from annual imaging and have decreased mortality rates compared to those who forgo preventive screening.
In the June 29 announcement, the ACR revealed CMS said the additional evidence provided to them was “insufficient” to support the reconsideration of their non-coverage decision.
In addition to CE-MRI's increased sensitivity for identifying breast cancers, the researchers also found the modality had superior negative likelihood ratios with higher pre-test probabilities for safely ruling out malignancy.
Assessing more than 11,000 patients with lesions designated as BI-RADS 4, radiologists using digital breast tomosynthesis found no significant diagnostic advantages over standard 2D mammography.
“These findings emphasize the importance of early recognition of IPV and timely intervention to prevent further harm to the victim,” authors of research published in Academic Radiology cautioned.